O'Connor, SM, Taylor, CE, Hughes, JM. Emerging infectious determinants of chronic diseases. Emerging Infectious Diseases
2006; 12: 1051–1057.
Izadi, M, et al.
Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease. Cardiovascular Pathology
2012; 21: 307–311.
Melnick, JL, et al.
Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. Journal of Medical Virology
1994; 42: 170–174.
Fraser, NW, et al.
Herpes simplex type 1 DNA in human brain tissue. Proceedings of the National Academy of Sciences USA
1981; 78: 6461–6465.
Marshall, BJ, Warren, JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet
1984; 1: 1311–1315.
Epstein, SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circulation Research
2002; 90: 2–4.
Kountouras, J, et al.
Association between Helicobacter pylori infection and mild cognitive impairment. European Journal of Neurology
2007; 14: 976–982.
Tarter, KD, et al.
Persistent viral pathogens and cognitive impairment across the lifecourse in the Third National Health and Nutrition Examination Survey. Journal of Infectious Diseases
2014; 209: 837–844.
Ferreira, AC, et al.
Helicobacter and gastric malignancies. Helicobacter
2008; 13 (Suppl. 1): 28–34.
Soroceanu, L, Cobbs, CS. Is HCMV a tumor promoter?
2011; 157: 193–203.
Epstein, SE, et al.
Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arteriosclerosis, Thrombosis, and Vascular Biology
2000; 20: 1417–1420.
Nazmi, A, et al.
The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health
2010; 10: 706.
Jackson, L, et al.
A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter
2009; 14: 108–113.
Emerging Risk Factors Collaboration
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet
2010; 375: 132–140.
Simanek, AM, Dowd, JB, Aiello, AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. International Journal of Epidemiology
2009; 38: 775–787.
Sealy-Jefferson, S, et al.
Antibody levels to persistent pathogens and incident stroke in Mexican Americans. PLoS ONE
2013; 8: e65959.
Aiello, AE, et al.
The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatric Society
2006; 54: 1046–1054.
Aiello, AE, et al.
Persistent infection, inflammation, and functional impairment in older latinos. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
2008; 63: 610–618.
Jeon, CY, et al.
Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care
2012; 35: 520–525.
Xia, HH, et al.
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. American Journal of Gastroenterology
2001; 96: 1039–1046.
Katan, M, et al.
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology
2013; 80: 1209–1215.
Miller, GE, et al.
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. American Journal of Cardiology
2005; 95: 317–321.
Fernandez-Real, J-M, et al.
Burden of Infection and insulin resistance in healthy middle-aged men. Diabetes Care
2006; 29: 1058–1064.
Zhu, J, et al.
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. American Journal of Cardiology
2000; 85: 140–146.
Zhu, J, et al.
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation
2001; 103: 45–51.
Elkind, MS, et al.
Infectious burden and risk of stroke: the northern Manhattan study. Archives of Neurology
2010; 67: 33–38.
Staras, SA, et al.
Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clinical Infectious Diseases
2006; 43: 1143–1151.
Schillinger, JA, et al.
National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976–1994. Sexually Transmitted Diseases
2004; 31: 753–760.
U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey (NHANES III.: 1988–1994. NHANES III Second Laboratory File Documentation Series 11, No. 2A. Hyattsville, Maryland: Centers for Disease Control and Prevention, 1998.
SUDAAN. Example Manual, Release 10·0·1. Research Triangle Park, NC.: Research Triangle Institute, 2010.
Benjamini, Y, Hochberg, Y. Controlling the false discovery rate – a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B: Methodological
1995; 57: 289–300.
Sun, Y, et al.
Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertension Research
2004; 27: 541–544.
de Luis, DA, et al.
Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care
1998; 21: 1129–1132.
Thomas, F, et al.
Herpes simplex virus type 2 and cancer: a medical geography approach. Infection, Genetics and Evolution
2011; 11: 1239–1242.
Beydoun, MA, et al.
Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosomatic Medicine
2013; 75: 486–496.
Colberg-Poley AM, Isom HC, Rapp F. Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus. Proceedings of the National Academy of Sciences USA
1979; 76: 5948–5951.
Colberg-Poley, AM, Isom, HC, Rapp, F. Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2. Journal of Virology
1981; 37: 1051–1059.
Strachan, DP, et al.
Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. British Medical Journal (Clinical Research Edition)
1999; 318: 1035–1039.